Marina Guillet

Founder and Chief Executive Officer @Samabriva

Nantes, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2018 — Present

Founder and Chief Executive Officer @Samabriva

View department →

Amiens, FR

Samabriva is a biotechnology company which has developed a disruptive bioproduction platform gathering the best of plants and usual biomanufacturing in fully controlled, affordable, scalable, sustainable and animal/virus-free bioprocesses currently being implemented by industrial companies for the production of high-value molecules (recombinant proteins and secondary metabolites).

EDUCATION

1999 — 2002

Nantes Université

PhD, Immunology

1998 — 1999

Université de Dijon-Besançon

Predoctoral Degree (D.E.A.), transplantation

2001 — 2002

IAE Nantes, Paris-Dauphine

Business Management

SKILLS

Gestion De ProjetSciences De La VieBiochimieR&DManagementExternal Referee for Anr (French National Research Agency) ProposalsBiotechnologySecteur PharmaceutiqueBiotechnologieBiologie MoléculaireTransfert TechnologiqueImmunologieBiophamarceutique

ABOUT MARINA GUILLET

Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Marina Guillet — Founder and Chief Executive Officer at Samabriva in Nantes, FR | Unifers